(NYSE: EHAB) Enhabit's forecast annual revenue growth rate of 4.94% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 6.25%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Enhabit's revenue in 2024 is $1,046,300,000.On average, 3 Wall Street analysts forecast EHAB's revenue for 2024 to be $54,389,251,804, with the lowest EHAB revenue forecast at $54,022,962,974, and the highest EHAB revenue forecast at $54,629,849,848. On average, 3 Wall Street analysts forecast EHAB's revenue for 2025 to be $56,971,781,154, with the lowest EHAB revenue forecast at $55,874,218,719, and the highest EHAB revenue forecast at $58,311,295,844.
In 2026, EHAB is forecast to generate $60,979,591,852 in revenue, with the lowest revenue forecast at $59,163,946,824 and the highest revenue forecast at $62,795,236,880.